Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06006923 |
| Title | Regorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Ibrahim Halil Sahin |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| City of Hope | NOT_YET_RECRUITING | Irvine | California | 92618 | United States | Details |
| AdventHealth Orlando | RECRUITING | Orlando | Florida | 32804 | United States | Details |
| University of Illinois Cancer Center | NOT_YET_RECRUITING | Chicago | Illinois | 60612 | United States | Details |
| UPMC Hillman Cancer Center | RECRUITING | Pittsburgh | Pennsylvania | 15232 | United States | Details |
| Fred Hutchinson Cancer Research Center | NOT_YET_RECRUITING | Seattle | Washington | 98109 | United States | Details |